201 related articles for article (PubMed ID: 28034547)
21. Impact of mobilization and remobilization strategies on achieving sufficient stem cell yields for autologous transplantation.
Pusic I; Jiang SY; Landua S; Uy GL; Rettig MP; Cashen AF; Westervelt P; Vij R; Abboud CN; Stockerl-Goldstein KE; Sempek DS; Smith AL; DiPersio JF
Biol Blood Marrow Transplant; 2008 Sep; 14(9):1045-1056. PubMed ID: 18721768
[TBL] [Abstract][Full Text] [Related]
22. Mobilization of PBSCs in poor mobilizers with POEMS syndrome using G-CSF with plerixafor.
Shimizu N; Sakaida E; Ohwada C; Takeuchi M; Kawaguchi T; Tsukamoto S; Sakai S; Takeda Y; Sugita Y; Yokote K; Iseki T; Isose S; Kanai K; Misawa S; Kuwabara S; Nakaseko C
Bone Marrow Transplant; 2012 Dec; 47(12):1587-8. PubMed ID: 22609884
[No Abstract] [Full Text] [Related]
23. Effectiveness and cost analysis of "just-in-time" salvage plerixafor administration in autologous transplant patients with poor stem cell mobilization kinetics.
Li J; Hamilton E; Vaughn L; Graiser M; Renfroe H; Lechowicz MJ; Langston A; Prichard JM; Anderson D; Gleason C; Lonial S; Flowers CR; Kaufman JL; Waller EK
Transfusion; 2011 Oct; 51(10):2175-82. PubMed ID: 21492180
[TBL] [Abstract][Full Text] [Related]
24. Use of recombinant human growth hormone (rhGH) plus recombinant human granulocyte colony-stimulating factor (rhG-CSF) for the mobilization and collection of CD34+ cells in poor mobilizers.
Carlo-Stella C; Di Nicola M; Milani R; Guidetti A; Magni M; Milanesi M; Longoni P; Matteucci P; Formelli F; Ravagnani F; Corradini P; Gianni AM
Blood; 2004 May; 103(9):3287-95. PubMed ID: 14726397
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of pre-emptively used plerixafor in patients mobilizing poorly after chemomobilization: a single centre experience.
Jantunen E; Kuittinen T; Mahlamäki E; Pyörälä M; Mäntymaa P; Nousiainen T
Eur J Haematol; 2011 Apr; 86(4):299-304. PubMed ID: 21198864
[TBL] [Abstract][Full Text] [Related]
26. Plerixafor: A chemokine receptor-4 antagonist for mobilization of hematopoietic stem cells for transplantation after high-dose chemotherapy for non-Hodgkin's lymphoma or multiple myeloma.
Steinberg M; Silva M
Clin Ther; 2010 May; 32(5):821-43. PubMed ID: 20685493
[TBL] [Abstract][Full Text] [Related]
27. Role of plerixafor in autologous stem cell mobilization with vinorelbine chemotherapy and granulocyte-colony stimulating factor in patients with myeloma: a phase II study (PAV-trial).
Schmid A; Friess D; Mansouri Taleghani B; Keller P; Mueller BU; Baerlocher GM; Leibundgut K; Pabst T
Leuk Lymphoma; 2015 Mar; 56(3):608-14. PubMed ID: 24884311
[TBL] [Abstract][Full Text] [Related]
28. Plerixafor on demand in ten healthy family donors as a rescue strategy to achieve an adequate graft for stem cell transplantation.
Gattillo S; Marktel S; Rizzo L; Malato S; Malabarba L; Coppola M; Assanelli A; Milani R; De Freitas T; Corti C; Bellio L; Ciceri F
Transfusion; 2015 Aug; 55(8):1993-2000. PubMed ID: 25721167
[TBL] [Abstract][Full Text] [Related]
29. Plerixafor is effective given either preemptively or as a rescue strategy in poor stem cell mobilizing patients with multiple myeloma.
Cheng J; Schmitt M; Wuchter P; Buss EC; Witzens-Harig M; Neben K; Hundemer M; Hillengass J; Alexi R; Goldschmidt H; Chen BA; Ho AD; Schmitt A
Transfusion; 2015 Feb; 55(2):275-83. PubMed ID: 25117969
[TBL] [Abstract][Full Text] [Related]
30. Plerixafor-augmented peripheral blood stem cell mobilization in AL amyloidosis with cardiac involvement: a case series.
Lee SY; Sanchorawala V; Seldin DC; Mark Sloan J; Andrea N; Quillen K
Amyloid; 2014 Sep; 21(3):149-53. PubMed ID: 24779777
[TBL] [Abstract][Full Text] [Related]
31. [Mobilization of peripheral blood stem cells with plerixafor in poor mobilizer patients].
Sancho JM; Duarte R; Medina L; Querol S; Marín P; Sureda A;
Med Clin (Barc); 2016 Sep; 147(5):223.e1-223.e7. PubMed ID: 27374031
[TBL] [Abstract][Full Text] [Related]
32. Plerixafor given before the third leukapheresis to rescue an unsuccessful stem cell mobilization with CY and G-CSF.
Nimmagadda S; Sweiss K; Mahmud N; Park Y; Rondelli D
Bone Marrow Transplant; 2010 Jun; 45(6):1121-2. PubMed ID: 19820726
[No Abstract] [Full Text] [Related]
33. Blood graft lymphocyte subsets after plerixafor injection in non-Hodgkin's lymphoma patients mobilizing poorly with chemotherapy plus granulocyte-colony-stimulating factor.
Varmavuo V; Mäntymaa P; Kuittinen T; Nousiainen T; Jantunen E
Transfusion; 2012 Aug; 52(8):1785-91. PubMed ID: 22304442
[TBL] [Abstract][Full Text] [Related]
34. Successful hematopoietic stem cell collection in patients who fail initial plerixafor mobilization for autologous stem cell transplant.
Veeraputhiran M; Jain T; Cronin S; Al-Kadhimi Z; Abidi MH; Ayash L; Mellert K; Lum LG; Ratanatharathorn V; Uberti JP; Deol A
J Clin Apher; 2014 Dec; 29(6):293-8. PubMed ID: 24700728
[TBL] [Abstract][Full Text] [Related]
35. An updated single center experience with plerixafor and granulocyte colony-stimulating factor for stem cell mobilization in light chain amyloidosis.
Badar T; Dhakal B; Szabo A; Padmanabhan A; Johnson BD; Heidtke S; Esselmann J; Chhabra S; Hamadani M; Hari P; D'Souza A
J Clin Apher; 2019 Dec; 34(6):686-691. PubMed ID: 31566813
[TBL] [Abstract][Full Text] [Related]
36. Can every patient be mobilized?
DiPersio JF
Best Pract Res Clin Haematol; 2010 Dec; 23(4):519-23. PubMed ID: 21130416
[TBL] [Abstract][Full Text] [Related]
37. Novel strategies for blood stem cell mobilization: special focus on plerixafor.
Jantunen E
Expert Opin Biol Ther; 2011 Sep; 11(9):1241-8. PubMed ID: 21806478
[TBL] [Abstract][Full Text] [Related]
38. Plerixafor in poor mobilizers with non-Hodgkin's lymphoma: a multi-center time-motion analysis.
Mohty M; Azar N; Chabannon C; Le Gouill S; Karlin L; Farina L; Milkovich G; Ostermann H; Glaß B; Noppeney R; Kron F; Kron A; Hübel K
Bone Marrow Transplant; 2018 Mar; 53(3):246-254. PubMed ID: 29255168
[TBL] [Abstract][Full Text] [Related]
39. Mobilisation of haematopoietic stem cells in paediatric patients, prior to autologous transplantation following administration of plerixafor and G-CSF.
Patel B; Pearson H; Zacharoulis S
Pediatr Blood Cancer; 2015 Aug; 62(8):1477-80. PubMed ID: 25755177
[TBL] [Abstract][Full Text] [Related]
40. A plerixafor-based strategy allows adequate hematopoietic stem cell collection in poor mobilizers: results from the Canadian Special Access Program.
Sheppard D; Bredeson C; Huebsch L; Allan D; Tay J
Bone Marrow Transplant; 2014 Jun; 49(6):751-5. PubMed ID: 24614838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
